Skip to main content

Table 2 Characteristics of the study cohort

From: Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women

Variable

North high IP N(%)

North low IP N(%)

Rotterdam high IP N(%)

Rotterdam low IP N(%)

Controls N(%)

6 hospitals

7 hospitals

5 hospitals

5 hospitals

7 hospitals

Mean age at diagnosis

61.16

61.48

61.33

61.40

59.80

SD 14.16

SD 14.20

SD 14.34

SD 14.39

SD 13.67

Period of diagnosis

     

1990-1995

3260 (23.21)

2095 (19.42)

2310 (23.16)

2249 (23.28)

4454 (23.38)

1996-2001

4079 (29.05)

3085 (28.60)

2717 (27.24)

2635 (27.28)

5131 (26.93)

2002-2007

4426 (31.52)

3558 (32.98)

3082 (30.90)

3044 (31.51)

5995 (31.47)

2008-2010

2278 (16.22)

2050 (19.00)

1866 (18.71)

1732 (17.93)

3470 (18.22)

Stage

     

IS

1097 (7.81)

776 (7.19)

794 (7.96)

775 (8.02)

1577 (8.28)

1

4758 (33.88)

3660 (33.93)

3323 (33.31)

3249 (33.63)

6595 (34.62)

2

5881 (41.88)

4575 (42.41)

4243 (42.54)

4097 (42.41)

7898 (41.46)

3

1480 (10.54)

1123 (10.41)

1018 (10.21)

959 (9.93)

1835 (9.63)

4

718 (5.11)

547 (5.07)

513 (5.14)

487 (5.04)

877 (4.60)

X

109 (0.78)

107 (0.99)

84 (0.84)

93 (0.96)

268 (1.41)

Average annual volume of hospital of diagnosis

     

<50

924 (6.58)

647 (6.00)

0 (0.00)

0 (0.00)

953 (5.00)

50-100

4226 (30.09)

10141 (94.00)

9975 (100)

9660 (100)

16.579 (87.03)

100 or more

8893 (63.33)

0 (0.00)

0 (0.00)

0 (0.00)

1518 (7.97)

  1. Characteristics of breast cancer patients according to the hospital category, 1990–2010, data are no (%), N = 63,516. IP = Implementation Proportion of recommendations given in the programme.